1 January 2015 in Journal of Experimental Neuroscience
Tauopathies are a class of neurodegenerative diseases characterized by the presence of hyperphosphorylated and aggregated tau pathology in neuronal and glial cells. Though the ratio of neuronal and glial tau aggregates varies across diseases, glial tau aggregates can populate the same degenerating brain regions as neuronal tau aggregates. While much is known about the deleterious consequences of tau pathology in neurons, the relative contribution of glial tau pathology to these diseases is less clear. Recent studies using a number of model systems implicate glial tau pathology in contributing to tauopathy pathogenesis. This review aims to highlight the functional consequences of tau overexpression in glial cells and explore the potential contribution of glial tau pathology in the pathogenesis of neurodegenerative tauopathies.
8 September 2025 in Journal of Biological Chemistry
Small molecules serve as valuable tools for probing non-apoptotic cell death mechanisms. The small molecule caspase independent lethal 56 (CIL56) induces a unique form of non-apoptotic cancer cell death that is promoted by a complex formed between zDHHC palmitoyltransferase 5 (ZDHHC5) and an accessory protein, golgin A7 (GOLGA7, also known as GCP16). The structure and function of this complex in non-apoptotic cell death regulation remain poorly understood. Here, we use co-immunoprecipitation, functional assays, and cryogenic electron microscopy (cryo-EM) to elucidate the structure of the Zdhhc5-GOLGA7 complex. We identify key residues in both Zdhhc5 and GOLGA7 that are necessary for complex formation and to promote non-apoptotic cancer cell death in response to CIL56. These results provide new insights into the structure and function of a death-promoting protein complex.